US Patent 11013728 Cyclin-dependent kinase 8 and/or 19 inhibitor
Patent 11013728 was granted and assigned to Kyoto Pharmaceutical Industries on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+273 characters)
Article
Patent abstract
The present invention aims to provide a novel cyclin-dependent kinase 8 and/or 19 inhibitor useful as an anti-cancer agent. The present invention relates to a cyclin-dependent kinase 8 and/or 19 inhibitor containing a compound represented by the formula (I):
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110137280
Date of Patent
May 25, 2021
0Patent Application Number
165003950
Date Filed
April 2, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110137280
Date of Patent
May 25, 2021
0Patent Application Number
165003950
Date Filed
April 2, 2018
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
US Patent 11013728 Cyclin-dependent kinase 8 and/or 19 inhibitor
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11013728
Date of patent
May 25, 2021
Patent application number
16500395
Date Filed
April 2, 2018
Patent citations
Patent primary examiner
Find more entities like US Patent 11013728 Cyclin-dependent kinase 8 and/or 19 inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.